For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Ceptyr, Inc.

USPTO Granted Patents = 15

Forward Citations = 36

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Ralf M Luche (12 out of 12 patents)

Bo Wei (12 out of 12 patents)

Maher Qabar (2 out of 7 patents)

4. Thomas Little (2 out of 21 patents)

5. William C Patt (2 out of 8 patents)

6. Mark Arnold Thomas Blaskovich (2 out of 7 patents)

7. Ted Baughman (2 out of 3 patents)

8. Gangadhar Nagula (2 out of 4 patents)

9. James Jeffry Howbert (2 out of 3 patents)

10. Jennifer Lynn Gage (2 out of 33 patents)

11. Richard Klinghoffer (1 out of 6 patents)

12. Feng Hong (1 out of 28 patents)

13. Lauri Marie Schultz (1 out of 1 patent)

14. Lauri Mario Schultz (1 out of 1 patent)

15. Stephen Patrick Lewis (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 7829737 - Protein tyrosine phosphatase inhibitors and methods of use thereof (2010-11-09),

2. 7504389 - Protein tyrosine phosphatase inhibitors and methods of use thereof (2009-03-17),

3. 7399586 - Modulation of biological signal transduction by RNA interference (2008-07-15),

4. 7279299 - DSP-10 dual-specificity phosphatase (2007-10-09),

5. 7078210 - DSP-3 dual-specificity phosphatase (2006-07-18),

6. 7037702 - DSP-10 dual-specificity phosphatase (2006-05-02),

7. 7029898 - DSP-11 dual-specificity phosphatase (2006-04-18),

8. 6902919 - DSP-12 and DSP-13 dual-specificity phosphatases (2005-06-07),

9. 6852520 - DSP-2 dual-specificity phosphatase (2005-02-08),

10. 6841369 - DSP-4 dual specificity phosphatase (2005-01-11),

11. 6825021 - DSP-15 dual-specificity phosphatase (2004-11-30),

12. 6649391 - DSP-11 dual-specificity phosphatase (2003-11-18),

13. 6645753 - DSP-5 dual-specificity phosphatase (2003-11-11),

14. 6551810 - DSP-10 dual-specificity phosphatase (2003-04-22),

15. 6492157 - DSP-9 dual-specificity phosphatase (2002-12-10),

Ceptyr, Inc. is a leading biotechnology company focused on the research and development of innovative therapeutics in the field of rare genetic diseases. With a strong commitment to improving patient lives, Ceptyr aims to discover and deliver breakthrough treatments that address unmet medical needs. Through close collaborations with academic institutions, healthcare professionals, and industry partners, Ceptyr is at the forefront of advancing scientific knowledge and translating it into transformative therapies. Visit our website to learn more about our mission, pipeline, and latest developments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#28 in Bothell, WA

#431 in Washington

#20,433 in US

#38,722 in the World

Bothell, WA, United States of America

Ceptyr, Inc.

Forward Citations = 36

15 inventors:

Ralf M Luche (12 out of 12 patents)

Bo Wei (12 out of 12 patents)

Maher Qabar (2 out of 7 patents)

4. Thomas Little (2 out of 21 patents)

5. William C Patt (2 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…